Skip to main content

Table 1 Characteristics of included studies (n = 81).

From: Use of Chinese medicine by cancer patients: a review of surveys

 

Number of studies

%

Year (in 5-year blocks)

   2010

7

8.6

   2009-2005

49

60.5

   2004-2000

22

27.2

   1999-1995

3

3.7

Country (by region)

   North America

35

43.2

   UK & Europe

20

24.7

   Asia

19

23.5

   Middle East

3

3.7

   Australia and New Zealand

3

3.7

   Multiple

1

1.2

Country or region (by individual countries or regions)

   US

27

33.3

   Canada

8

9.9

   UK

7

8.6

   Europe

6

7.4

   Taiwan

4

4.9

   Other individual countries

29

35.9

Group setting

   Hospital including outpatient clinics, cancer institutes, palliative care

57

70.4

   Cancer/tumour registry

12

14.8

   General Population

6

7.4

   Other

6

7.4

Data Collection Methods

   Self-report questionnaire

42

51.9

   Interviewer led (in person or telephone)

37

45.7

   Database e.g. insurance claims

2

2.5

Sampling method

   Random

18

22.2

   Systematic

6

7.4

   Stratified

7

8.6

   Convenience

50

61.7

Cancer type

   Various (mixed cancers within groups)

40

49.4

   Breast

21

25.9

   Prostate

5

6.2

   Other

15

18.5

Gender, mean %

   Female

 

66.7

   Male

 

33.2

Age, mean (Missing data = 31)

56.0

 

Marital status, mean % (Missing data = 34)

   Married or de-facto

 

70.6

   Other

 

29.4

Education, mean % (Missing data = 27)

   Primary School

 

12.3

   High School

 

35.8

   University

 

18.5